217 related articles for article (PubMed ID: 32793603)
21. Expression and function of P-selectin glycoprotein ligand 1 (CD162) on human basophils.
Taylor ML; Brummet ME; Hudson SA; Miura K; Bochner BS
J Allergy Clin Immunol; 2000 Nov; 106(5):918-24. PubMed ID: 11080715
[TBL] [Abstract][Full Text] [Related]
22. Contrasting effects of P-selectin and E-selectin on the differentiation of murine hematopoietic progenitor cells.
Eto T; Winkler I; Purton LE; Lévesque JP
Exp Hematol; 2005 Feb; 33(2):232-42. PubMed ID: 15676218
[TBL] [Abstract][Full Text] [Related]
23. Spatiotemporal expression dynamics of selectins govern the sequential extravasation of neutrophils and monocytes in the acute inflammatory response.
Zuchtriegel G; Uhl B; Hessenauer ME; Kurz AR; Rehberg M; Lauber K; Krombach F; Reichel CA
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):899-910. PubMed ID: 25722429
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of cytokines and soluble adhesion molecules in patients with newly diagnosed acute myeloid leukemia: the role of TNF-alpha and FLT3-ITD.
Kupsa T; Vanek J; Vasatova M; Karesova I; Zak P; Jebavy L; Horacek JM
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Mar; 160(1):94-9. PubMed ID: 26365931
[TBL] [Abstract][Full Text] [Related]
25. Activation of human leukocytes reduces surface P-selectin glycoprotein ligand-1 (PSGL-1, CD162) and adhesion to P-selectin in vitro.
Davenpeck KL; Brummet ME; Hudson SA; Mayer RJ; Bochner BS
J Immunol; 2000 Sep; 165(5):2764-72. PubMed ID: 10946308
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-8 blockade prevents activated endothelial cell mediated proliferation and chemoresistance of acute myeloid leukemia.
Vijay V; Miller R; Vue GS; Pezeshkian MB; Maywood M; Ast AM; Drusbosky LM; Pompeu Y; Salgado AD; Lipten SD; Geddes T; Blenc AM; Ge Y; Ostrov DA; Cogle CR; Madlambayan GJ
Leuk Res; 2019 Sep; 84():106180. PubMed ID: 31299413
[TBL] [Abstract][Full Text] [Related]
27. Structure and function of P-selectin glycoprotein ligand-1.
Moore KL
Leuk Lymphoma; 1998 Mar; 29(1-2):1-15. PubMed ID: 9638971
[TBL] [Abstract][Full Text] [Related]
28. Distinct roles of mesenchymal stem and progenitor cells during the development of acute myeloid leukemia in mice.
Xiao P; Sandhow L; Heshmati Y; Kondo M; Bouderlique T; Dolinska M; Johansson AS; Sigvardsson M; Ekblom M; Walfridsson J; Qian H
Blood Adv; 2018 Jun; 2(12):1480-1494. PubMed ID: 29945938
[TBL] [Abstract][Full Text] [Related]
29. Bone marrow niche-mediated survival of leukemia stem cells in acute myeloid leukemia: Yin and Yang.
Zhou HS; Carter BZ; Andreeff M
Cancer Biol Med; 2016 Jun; 13(2):248-59. PubMed ID: 27458532
[TBL] [Abstract][Full Text] [Related]
30. The bone marrow microenvironment - Home of the leukemic blasts.
Shafat MS; Gnaneswaran B; Bowles KM; Rushworth SA
Blood Rev; 2017 Sep; 31(5):277-286. PubMed ID: 28318761
[TBL] [Abstract][Full Text] [Related]
31. Vascular endothelial growth factor-C modulates proliferation and chemoresistance in acute myeloid leukemic cells through an endothelin-1-dependent induction of cyclooxygenase-2.
Hua KT; Lee WJ; Yang SF; Chen CK; Hsiao M; Ku CC; Wei LH; Kuo ML; Chien MH
Biochim Biophys Acta; 2014 Feb; 1843(2):387-97. PubMed ID: 24184161
[TBL] [Abstract][Full Text] [Related]
32. Notch signalling drives bone marrow stromal cell-mediated chemoresistance in acute myeloid leukemia.
Takam Kamga P; Bassi G; Cassaro A; Midolo M; Di Trapani M; Gatti A; Carusone R; Resci F; Perbellini O; Gottardi M; Bonifacio M; Nwabo Kamdje AH; Ambrosetti A; Krampera M
Oncotarget; 2016 Apr; 7(16):21713-27. PubMed ID: 26967055
[TBL] [Abstract][Full Text] [Related]
33. The CCL2/CCR2 Axis Affects Transmigration and Proliferation but Not Resistance to Chemotherapy of Acute Myeloid Leukemia Cells.
Macanas-Pirard P; Quezada T; Navarrete L; Broekhuizen R; Leisewitz A; Nervi B; Ramírez PA
PLoS One; 2017; 12(1):e0168888. PubMed ID: 28045930
[TBL] [Abstract][Full Text] [Related]
34. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
Lu C; Hassan HT
Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
[TBL] [Abstract][Full Text] [Related]
35. Role of the bone marrow vascular niche in chemotherapy for MLL-AF9-induced acute myeloid leukemia.
Xu C; Lu T; Lv X; Cheng T; Cheng H
Blood Sci; 2023 Apr; 5(2):92-100. PubMed ID: 37228781
[TBL] [Abstract][Full Text] [Related]
36. RUNX1/ETO blocks selectin-mediated adhesion via epigenetic silencing of PSGL-1.
Ponnusamy K; Kohrs N; Ptasinska A; Assi SA; Herold T; Hiddemann W; Lausen J; Bonifer C; Henschler R; Wichmann C
Oncogenesis; 2015 Apr; 4(4):e146. PubMed ID: 25867177
[TBL] [Abstract][Full Text] [Related]
37. TGF-β1 and CXCL12 modulate proliferation and chemotherapy sensitivity of acute myeloid leukemia cells co-cultured with multipotent mesenchymal stromal cells.
Schelker RC; Iberl S; Müller G; Hart C; Herr W; Grassinger J
Hematology; 2018 Jul; 23(6):337-345. PubMed ID: 29140182
[TBL] [Abstract][Full Text] [Related]
38. Heme Oxygenase 1-Targeted Hybrid Nanoparticle for Chemo- and Immuno-Combination Therapy in Acute Myelogenous Leukemia.
Yong SB; Kim J; Chung JY; Ra S; Kim SS; Kim YH
Adv Sci (Weinh); 2020 Jul; 7(13):2000487. PubMed ID: 32670766
[TBL] [Abstract][Full Text] [Related]
39. The role of platelet/endothelial cell adhesion molecule 1 (CD31) and CD38 antigens in marrow microenvironmental retention of acute myelogenous leukemia cells.
Gallay N; Anani L; Lopez A; Colombat P; Binet C; Domenech J; Weksler BB; Malavasi F; Herault O
Cancer Res; 2007 Sep; 67(18):8624-32. PubMed ID: 17875702
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-1β inhibits normal hematopoietic expansion and promotes acute myeloid leukemia progression via the bone marrow niche.
Wang Y; Sun X; Yuan S; Hou S; Guo T; Chu Y; Pang T; Luo HR; Yuan W; Wang X
Cytotherapy; 2020 Mar; 22(3):127-134. PubMed ID: 32024607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
